BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2815886)

  • 1. [The diagnostic significance of mucoproteins, sialic acid and cortisol in assessing the activity of rheumatic diseases].
    Paul R; Rotzsch W
    Z Gesamte Inn Med; 1989 Jul; 44(14):410-3. PubMed ID: 2815886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of the determination of mucoproteins and sialic acid in the blood serum for estimating the activity of rheumatism and rheumatoid arthritis].
    Kyrge KKh; Valgma KA; Poolak VI
    Vopr Revm; 1965; 5(4):29-33. PubMed ID: 5298237
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycoproteins as markers of inflammation in rheumatic disorders.
    Kulkarni AV; Engineer JJ; Sequira RD; Borges NE; Joshi VR
    J Postgrad Med; 1986 Apr; 32(2):89-93. PubMed ID: 3761215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison among the blood sialic acid level, CRP, protein fractions and mucoprotein content].
    Igari J; Kosakai N; Ozawa M; Kawabata S
    Rinsho Byori; 1983 Mar; Suppl 54():81-8. PubMed ID: 6887586
    [No Abstract]   [Full Text] [Related]  

  • 5. [On mucoproteins in the blood in arthropathies. Evaluation of the phlogistic significance of mucoproteins as compared with other indices of inflammation].
    Ferri S; Pazzaglia Minghetti B; Sabatino S; Galavotti B
    Reumatismo; 1972; 24(1):36-48. PubMed ID: 4671627
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucoproteins, sialic acid and haptoglobin in collagenoses in children.
    Boguslawska-Jaworska J; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1967; 15(6):858-67. PubMed ID: 5587693
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of the determination of the N-acetylneuraminic acid level as compared with other clinical tests in the evaluation of acute phases of rheumatic diseases].
    Baniowski A; Gumiński T
    Przegl Lek; 1966; 22(4):353-5. PubMed ID: 5912452
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes of the blood sialic acid and acute phase reactant levels in chronic rheumatoid arthritis].
    Warabi H; Yamada E; Shiokawa Y
    Rinsho Byori; 1983 Mar; Suppl 54():113-9. PubMed ID: 6193298
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of rheumatic diseases: tests and traps.
    Schmidt MC
    Hosp Pract (Off Ed); 1984 Sep; 19(9):82E-82G, 82K, 82O passim. PubMed ID: 6432827
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alpha-1-acid glycoprotein in differential diagnosis of rheumatic diseases].
    Aeschlimann A; Pawlowski T; Fassbender K; Mackiewicz SH; Müller W
    Med Klin (Munich); 1991 Oct; 86(10):491-7. PubMed ID: 1758370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The behavior of fucose and neuraminic acid in rheumatic disease].
    Rossolini A; Pieri J; Puglisi P; Bianchini AM
    Riv Clin Pediatr; 1966 Dec; 78(6):737-43. PubMed ID: 5999594
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum mucoprotein tyrosine in rheumatism.
    Singh SD; Chhaparwal BC; Deshpande V
    Indian J Pediatr; 1971 Aug; 38(283):323-5. PubMed ID: 5316478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differential evaluation of the degree of activity of the rheumatic process in children].
    Sokolova-Ponomareva OD; Gataullina LD
    Sov Med; 1967 May; 30(5):99-102. PubMed ID: 5305171
    [No Abstract]   [Full Text] [Related]  

  • 14. [Refined diagnosis of C-reactive protein for the detection and course control of chronic inflammatory rheumatic processes].
    Peter A
    Z Gesamte Inn Med; 1976 May; 31(10):330-3. PubMed ID: 822608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of inflammation markers in the "essential laboratory tests" to new outpatients and analysis for the efficacious selection of these items].
    Takemura Y; Matsuta H; Kugai N; Sekiguchi S
    Rinsho Byori; 1994 Oct; 42(10):1055-61. PubMed ID: 7996715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the behavior of fucose, sialic acid and mucoproteins in patients with malignant neoplasms before and after roentgen therapy].
    Guerrina G; Traverso G
    Pathologica; 1970; 62(907):75-8. PubMed ID: 5523517
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of water soluble and lipid soluble sialic acid levels as tumor markers.
    Shamberger RJ
    Anticancer Res; 1986; 6(4):717-20. PubMed ID: 3752951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acid alpha-glycoprotein, mucoprotein and erythrocyte sedimentation rate in infantile rheumatic disease. Correlations and regression].
    Mignone F; Licata D; Chiappo GF; Oggero R
    Minerva Pediatr; 1976 Nov; 28(34):2057-62. PubMed ID: 1087691
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of sialic acid on the ESR.
    Lugton RA
    Med Lab Sci; 1989 Jan; 46(1):33-8. PubMed ID: 2779380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Judicious use of biological tests in rheumatology].
    Aeschlimann A; Müller W
    Schweiz Rundsch Med Prax; 1991 Nov; 80(47):1312-7. PubMed ID: 1957096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.